KleenFoam Lawsuit | 2025 Latest Updates

KleenFoam antimicrobial foam soap has been recalled nationwide after testing revealed contamination with Burkholderia cepacia complex, a dangerous bacterium that can cause severe infections. Individuals who became ill after using the product may be entitled to compensation through a KleenFoam lawsuit.
Award Logos
C.L. Mike Schmidt Published by C.L. Mike Schmidt

If you or someone in your home used KleenFoam antimicrobial foam soap and developed a serious infection or medical complication, you may be eligible to pursue legal action. At Schmidt &Clark, we represent individuals harmed by contaminated consumer health products.

Our dedicated legal team can assist you in collecting necessary documentation, assessing your case, and advocating for the compensation you deserve. Contact Schmidt &Clark today for a free, no-obligation consultation.

What’s the Problem?

KleenFoam antimicrobial foam soap is part of a voluntary nationwide recall initiated by DermaRite Industries due to contamination with Burkholderia cepacia complex—a dangerous pathogen known to cause serious infections, especially in individuals with compromised immune systems.

Though no illnesses have been officially reported, KleenFoam users exposed via compromised skin or those caring for at-risk individuals may face elevated risk of infection, including respiratory or bloodstream complications, or sepsis.

Latest KleenFoam Lawsuit Updates

  • August 8, 2025 – DermaRite announces immediate voluntary nationwide recall of KleenFoam and related DermaRite products found to be contaminated [1.].

KleenFoam Lawsuit Scope & Stats

  • Product involved: KleenFoam antimicrobial foam soap (with other DermaRite soaps).
  • Distribution: Nationwide across pharmacies, hospitals, clinics, and online stores.
  • Reported harms: No confirmed infections yet, though risk remains significant for vulnerable users.
  • Legal activity: No filed lawsuits; our firm is beginning outreach to potentially impacted consumers.

Safety Risk Analysis

  • KleenFoam was marketed as a gentle, effective antimicrobial product; contamination with B. cepacia undermines this safety claim.
  • This bacterium can colonize lungs or wounds—with the risk of pneumonia or systemic infection.
  • Particularly risky for patients with cystic fibrosis, chronic lung conditions, or open wounds.

Possible Health Impacts

Contamination may lead to:

  • Skin infections: Rash, tenderness, or abscess formation at application sites.
  • Severe respiratory infection: Cough, fever, or breathing difficulties requiring hospitalization.
  • Systemic sepsis: Bloodstream invasion causing shock, organ failure, or intensive care admission.

Do You Qualify for a KleenFoam Lawsuit?

  • You used KleenFoam foam soap from a lot covered by the August 2025 recall.
  • You or a family member became ill or was medically evaluated for infection shortly after use.
  • Your healthcare provider linked symptoms to potential contamination.
  • You kept medical records, subpoenas, or packaging identifying the product.
  • No lawsuit has been filed on your behalf and you are seeking legal guidance.

Evidence You Should Gather

  • Product evidence: Receipt, lot numbers, or photos of packaging.
  • Medical proof: Doctor’s notes, hospital records, test results.
  • Symptom log: Timeline of use and onset date of symptoms.
  • Recall documentation: Official notification referencing KleenFoam recall.

Damages You Can Recover

  • Medical and hospital expenses for infection treatment.
  • Reimbursement for lost work or caregiving costs.
  • Pain and suffering, especially for systemic or life-threatening conditions.
  • Punitive damages, in cases of gross negligence in manufacturing or safety oversight.

Recall Summary

  • Recall Date: August 8, 2025
  • Product: KleenFoam antimicrobial foam soap
  • Hazard: Contamination with B. cepacia complex
  • Distribution: National—through healthcare and retail channels
  • Recommendations: Discontinue use, safely dispose, and seek physician evaluation if symptoms arise

Statute of Limitations & Urgency

Product liability claims typically must be filed within two to three years from injury or discovery date. With the contamination recall having taken place in August 2025, potential plaintiffs should consult legal counsel as soon as possible to avoid losing rights. Special timing may apply in infection cases or in jurisdictions with enhanced protections—early action is essential.

Frequently Asked Questions

  • How do I initiate a claim? Reach out to Schmidt &Clark or a product liability attorney with documentation of exposure and medical effects.
  • Who can file? Anyone affected by KleenFoam contamination, including users or caregivers of vulnerable individuals.
  • Is emotional trauma covered? Yes—cases involving serious or systemic illness may qualify for non-economic damage awards.
  • Products to keep? Keep any remaining packaging, receipts, and medical documentation—even photographs help.
  • No infection detected? Still consult a healthcare provider—documented evaluations may support preventive claim eligibility.

Start Your Free Case Review Now

References

  1. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dermarite-industries-issues-voluntary-nationwide-recall-dermakleen-dermasarra-kleenfoam-and

Get a Free Case Review

You may be entitled to financial compensation.
  • This field is for validation purposes and should be left unchanged.
Secure Submission